CompletedNot Applicable

Intrastromal Injection of Fluconazole in Treatment of Fungal Keratitis

Egypt40 participantsStarted 2022-01-01

Plain-language summary

This study aimed to evaluate the Safety and the Effectiveness of Intrastromal Injection of Fluconazole in The Treatment of Fungal Keratitis.

Who can participate

Age range30 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients diagnosed both clinically and laboratory as fungal keratitis. * Fungal cultures should be sensitive to fluconazole. Exclusion Criteria: * Thin cornea. * Decmatocele. * Necrotic or perforated corneal ulcers. * Other types of keratitis (bacterial or viral). * Fungal cultures resistant to fluconazole. * Patients on immune-suppressants drugs. * Silicon oil filled eyes. * Previous ocular surgery e.g keratoplasty.

What they're measuring

Best-corrected visual acuity

Timeframe: Every three days until complete healing (Up to 6 weeks)

Trial details

NCT IDNCT07557966

SponsorTanta University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-12-01

View on ClinicalTrials.gov More Safety trials